{
    "2021-03-17": [
        [
            {
                "time": "",
                "original_text": "A股史上首次蓝筹股泡沫破裂，6成私募反对抄底",
                "features": {
                    "keywords": [
                        "蓝筹股",
                        "泡沫破裂",
                        "私募",
                        "抄底"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-29",
                "original_text": "泰格医药(03347.HK)3月29日举行董事会会议审批年度业绩",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "董事会会议",
                        "年度业绩"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-17",
                "original_text": "3月17日晚间重要行业研究汇总(附股)",
                "features": {
                    "keywords": [
                        "行业研究",
                        "汇总"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "渤海证券 - 医药行业周报：关注一季度业绩同比增长的优质个股【行业研究】",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "周报",
                        "一季度业绩",
                        "优质个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)涨3.22%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "异动股",
                        "涨3.22%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】关注一季度业绩同比增长的优质个股――医药行业周报――中性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "一季度业绩",
                        "优质个股"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "正面刚！4000亿“猪茅”回应六大质疑",
                "features": {
                    "keywords": [
                        "猪茅",
                        "回应",
                        "质疑"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}